Skip to Content

Biomerica Inc BMRA

Morningstar Rating
$0.34 +0.01 (1.55%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

BMRA is trading at a 623% premium.
Price
$0.33
Fair Value
$9.62
Uncertainty
Extreme
1-Star Price
$8.72
5-Star Price
$5.84
Economic Moat
Njl
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if BMRA is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$0.33
Day Range
$0.330.35
52-Week Range
$0.282.13
Bid/Ask
$0.33 / $0.34
Market Cap
$5.64 Mil
Volume/Avg
23,003 / 242,430

Key Statistics

Price/Earnings (Normalized)
Price/Sales
1.02
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Europe market.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Value
Total Number of Employees
62

Valuation

Metric
BMRA
Price/Earnings (Normalized)
Price/Book Value
0.71
Price/Sales
1.02
Price/Cash Flow
Price/Earnings
BMRA

Financial Strength

Metric
BMRA
Quick Ratio
4.50
Current Ratio
5.63
Interest Coverage
Quick Ratio
BMRA

Profitability

Metric
BMRA
Return on Assets (Normalized)
−49.16%
Return on Equity (Normalized)
−62.49%
Return on Invested Capital (Normalized)
−59.15%
Return on Assets
BMRA
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Abbott Laboratories
ABT
KxpcsbgxQllctg$174.1 Bil
Stryker Corp
SYK
JxlntrdldSsd$126.2 Bil
Boston Scientific Corp
BSX
KnzrbzkKdpgx$111.1 Bil
Medtronic PLC
MDT
FtvxwrdfPbcpgw$104.1 Bil
Edwards Lifesciences Corp
EW
XymtwwztxtPhzbyc$51.7 Bil
DexCom Inc
DXCM
ByrrwnqkrGctck$43.8 Bil
Koninklijke Philips NV ADR
PHG
VydfzwlsWlmgmp$24.7 Bil
Zimmer Biomet Holdings Inc
ZBH
FqsypqqfkMlrvx$22.9 Bil
Steris PLC
STE
FgkynsbRptjmqt$22.3 Bil
Align Technology Inc
ALGN
CffpprmjsCtvczfq$18.9 Bil

Sponsor Center